Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Myfortic in the Treatment of Uveitis: Pilot Study
2006-004709-24Phase 2Active
- Sponsor
- Erasmus MC
- Start
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of mycophenolate sodium in uveitis (2 arms), sponsored by Erasmus MC. Primary endpoint: Therapeutic equality between Myfortic and cyclosporine. Started Sep 2006; status: active.
02
Drugs
mycophenolate sodium
03
Conditions
uveitis
Beyond the preview
Go deeper on 2006-004709-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004709-24.